Skip to content
Home
Phillip M. Rappold, M.D., Ph.D.

Phillip M. Rappold, M.D., Ph.D.

Contact

Appointment (585) 275-2838

About Me

Faculty Appointments

Assistant Professor - Department of Urology (SMD)

Credentials

Post-doctoral Training & Residency

Fellowship, Fellow, Memorial Sloan-Kettering Cancer Center. 2020 - 2022

Residency, Resident, University of Rochester Medical Center. 2015 - 2020

Internship, Surgery (General Surgery), University of Rochester Medical Center. 2014 - 2015

Education

MD | University of Rochester. 2014

PHD | University of Rochester. 2013

Publications

Journal Articles

Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma.

Chakiryan NH, Kim Y, Berglund A, Chang A, Kimmel GJ, Hajiran A, Nguyen J, Moran-Segura C, Saeed-Vafa D, Katende EN, Lopez-Blanco N, Chahoud J, Rappold P, Spiess PE, Fournier M, Jeong D, Wang L, Teer JK, Dhillon J, Kuo F, Hakimi AA, Altrock PM, Mulé JJ, Manley BJ

Journal for immunotherapy of cancer.. 2023 April 11 (4)Epub 1900 01 01.

Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape.

Golkaram M, Kuo F, Gupta S, Carlo MI, Salmans ML, Vijayaraghavan R, Tang C, Makarov V, Rappold P, Blum KA, Zhao C, Mehio R, Zhang S, Godsey J, Pawlowski T, DiNatale RG, Morris LGT, Durack J, Russo P, Kotecha RR, Coleman J, Chen YB, Reuter VE, Motzer RJ, Voss MH, Liu L, Reznik E, Chan TA, Hakimi AA

Genome medicine.. 2022 December 1914 (1):143. Epub 12/19/2022.

TMEM27 expression and clinical characteristics and survival in clear cell renal cell carcinoma.

Grewal R, Choung HYG, Roberts LL, Beane T, Chen L, Gilroy DX, Rappold PM, Le TH

Acta oncologica.. 2022 November 11 :1-5. Epub 11/11/2022.

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.

Rappold PM, Vuong L, Leibold J, Chakiryan NH, Curry M, Kuo F, Sabio E, Jiang H, Nixon BG, Liu M, Berglund AE, Silagy AW, Mascareno EA, Golkaram M, Marker M, Reising A, Savchenko A, Millholland J, Chen YB, Russo P, Coleman J, Reznik E, Manley BJ, Ostrovnaya I, Makarov V, DiNatale RG, Blum KA, Ma X, Chowell D, Li MO, Solit DB, Lowe SW, Chan TA, Motzer RJ, Voss MH, Hakimi AA

Cancer discovery.. 2022 October 512 (10):2308-2329. Epub 1900 01 01.

Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell Carcinoma.

Silagy AW, Tin AL, Rappold P, Vertosick EA, Mano R, Attalla K, Yoo A, Weng S, DiNatale RG, Vickers AJ, Sjoberg DD, Coleman JA, Russo P, Hakimi AA

Clinical genitourinary cancer.. 2022 October 20 (5):e432-e439. Epub 05/25/2022.

Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.

Yoo A, Tang C, Zucker M, Fitzgerald K, DiNatale RG, Rappold PM, Weiss K, Freeman B, Lee CH, Schultz N, Motzer R, Russo P, Coleman J, Reuter VE, Chen YB, Carlo MI, Gill AJ, Kotecha RR, Ari Hakimi A, Reznik E

European urology focus.. 2022 September 8 (5):1278-1288. Epub 03/11/2022.

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma.

Attalla K, DiNatale RG, Rappold PM, Fong CJ, Sanchez-Vega F, Silagy AW, Weng S, Coleman J, Lee CH, Carlo MI, Durack JC, Solomon SB, Reuter VE, Russo P, Chan TA, Motzer RJ, Schultz ND, Reznik E, Voss MH, Hakimi AA

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2021 October 1527 (20):5595-5606. Epub 07/14/2021.

Design and Implementation of an Emergency Undocking Curriculum for Robotic Surgery.

Melnyk R, Saba P, Holler T, Cameron K, Mithal P, Rappold P, Wu G, Cubillos J, Rashid H, Joseph JV, Ghazi AE

Simulation in healthcare : journal of the Society for Simulation in Healthcare.. 2021 August 11 Epub 08/11/2021.

Immune checkpoint blockade in renal cell carcinoma.

Rappold PM, Silagy AW, Kotecha RR, Hakimi AA

Journal of surgical oncology.. 2021 March 123 (3):739-750. Epub 1900 01 01.